$CPAY
CORPAY, INC.

2024 Q2 Form 10-Q Financial Statement

#000162828024021986 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $975.7M $935.3M $901.3M
YoY Change 2.9% 3.77% 14.2%
Cost Of Revenue $209.2M $207.4M
YoY Change
Gross Profit $766.5M $727.8M
YoY Change
Gross Profit Margin 78.56% 77.82%
Selling, General & Admin $248.8M $245.5M $441.2M
YoY Change 1.24% -44.37% 100.19%
% of Gross Profit 32.46% 33.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $84.34M $28.93M $84.23M
YoY Change 0.8% -65.65% 298.45%
% of Gross Profit 11.0% 3.97%
Operating Expenses $248.8M $245.5M $526.1M
YoY Change 1.24% -53.35% 138.71%
Operating Profit $433.3M $397.3M $375.2M
YoY Change 5.01% 5.9% 18.09%
Interest Expense -$90.74M -$85.82M -$79.61M
YoY Change 3.58% 7.81% -164.5%
% of Operating Profit -20.94% -21.6% -21.22%
Other Income/Expense, Net -$99.14M -$92.05M -$746.0K
YoY Change 15.17% 12238.87% -96.76%
Pretax Income $334.2M $305.3M $294.8M
YoY Change 2.34% 3.54% 0.06%
Income Tax $82.54M $75.49M $80.01M
% Of Pretax Income 24.7% 24.73% 27.14%
Net Earnings $251.6M $229.8M $214.8M
YoY Change 4.97% 6.95% -1.43%
Net Earnings / Revenue 25.79% 24.57% 23.84%
Basic Earnings Per Share $3.59 $3.20 $2.92
Diluted Earnings Per Share $3.52 $3.12 $2.88
COMMON SHARES
Basic Shares Outstanding 70.27M shares 71.85M shares 73.49M shares
Diluted Shares Outstanding 71.50M shares 73.55M shares 74.48M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.358B $1.312B $1.272B
YoY Change 8.24% 3.1% -1.99%
Cash & Equivalents $1.358B $1.312B $1.272B
Short-Term Investments
Other Short-Term Assets $2.797B $2.328B $1.433B
YoY Change 42.66% 62.45% 26.02%
Inventory
Prepaid Expenses
Receivables $2.412B $2.376B $2.369B
Other Receivables $1.409B $1.421B $1.284B
Total Short-Term Assets $7.976B $7.437B $6.359B
YoY Change 15.2% 16.96% 2.96%
LONG-TERM ASSETS
Property, Plant & Equipment $357.8M $351.8M $310.4M
YoY Change 8.69% 13.35% 21.99%
Goodwill $5.546B $5.674B $5.380B
YoY Change 1.32% 5.46% 3.85%
Intangibles $1.957B $2.033B $2.198B
YoY Change -7.13% -7.48% -5.04%
Long-Term Investments $64.04M $68.30M $67.59M
YoY Change -8.15% 1.05% -4.89%
Other Assets $296.2M $265.8M $273.3M
YoY Change 7.51% -2.76% 21.75%
Total Long-Term Assets $8.221B $8.393B $8.229B
YoY Change -0.41% 1.99% 2.28%
TOTAL ASSETS
Total Short-Term Assets $7.976B $7.437B $6.359B
Total Long-Term Assets $8.221B $8.393B $8.229B
Total Assets $16.20B $15.83B $14.59B
YoY Change 6.71% 8.52% 2.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.903B $1.850B $1.908B
YoY Change 13.29% -3.03% -2.51%
Accrued Expenses $367.8M $408.7M $404.9M
YoY Change -6.34% 0.92% 7.59%
Deferred Revenue $2.764B $2.534B $2.031B
YoY Change 20.92% 24.78%
Short-Term Debt $1.409B $1.421B $0.00
YoY Change -100.0%
Long-Term Debt Due $2.516B $1.901B $2.097B
YoY Change 21.46% -9.33% 8.83%
Total Short-Term Liabilities $7.843B $6.951B $6.204B
YoY Change 21.86% 12.05% 1.83%
LONG-TERM LIABILITIES
Long-Term Debt $4.818B $4.863B $4.701B
YoY Change 2.98% 3.45% 6.44%
Other Long-Term Liabilities $315.6M $261.1M $257.3M
YoY Change 20.33% 1.47% 16.92%
Total Long-Term Liabilities $5.578B $5.597B $4.958B
YoY Change 1.81% 12.89% -5.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.843B $6.951B $6.204B
Total Long-Term Liabilities $5.578B $5.597B $4.958B
Total Liabilities $13.42B $12.55B $11.71B
YoY Change 12.64% 7.19% 3.44%
SHAREHOLDERS EQUITY
Retained Earnings $8.674B $8.422B $7.426B
YoY Change 13.16% 13.42% 14.69%
Common Stock $3.419B $3.382B $3.109B
YoY Change 7.62% 8.78% 6.47%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.843B $7.209B
YoY Change
Treasury Stock Shares
Shareholders Equity $2.751B $3.254B $2.882B
YoY Change
Total Liabilities & Shareholders Equity $16.20B $15.83B $14.59B
YoY Change 6.71% 8.52% 2.58%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $251.6M $229.8M $214.8M
YoY Change 4.97% 6.95% -1.43%
Depreciation, Depletion And Amortization $84.34M $28.93M $84.23M
YoY Change 0.8% -65.65% 298.45%
Cash From Operating Activities $540.9M $350.2M $327.7M
YoY Change 8.4% 6.87% -391.9%
INVESTING ACTIVITIES
Capital Expenditures $44.10M $41.19M $36.74M
YoY Change 4.53% 12.13% 17.05%
Acquisitions $56.33M $126.7M
YoY Change -55.54% 253.25%
Other Investing Activities -$173.0K $4.826M -$122.3M
YoY Change 5666.67% -103.95% 240.98%
Cash From Investing Activities -$44.27M -$102.3M -$159.0M
YoY Change 4.93% -35.64% 136.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -80.69M -$158.6M -217.7M
YoY Change 234.86% -27.17% 336.99%
NET CHANGE
Cash From Operating Activities 540.9M $350.2M 327.7M
Cash From Investing Activities -44.27M -$102.3M -159.0M
Cash From Financing Activities -80.69M -$158.6M -217.7M
Net Change In Cash 416.0M $61.14M -49.08M
YoY Change -3.87% -224.58% -69.57%
FREE CASH FLOW
Cash From Operating Activities $540.9M $350.2M $327.7M
Capital Expenditures $44.10M $41.19M $36.74M
Free Cash Flow $496.8M $309.0M $290.9M
YoY Change 8.75% 6.21% -302.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
437687000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
474144000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
7437366000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7084265000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
351831000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
343154000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
5673732000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5644958000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2033106000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2085663000 usd
CY2024Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
68299000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
69521000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
265797000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
248691000 usd
CY2024Q1 us-gaap Assets
Assets
15830131000 usd
CY2023Q4 us-gaap Assets
Assets
15476252000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1849958000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1624995000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
408661000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
356118000 usd
CY2024Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
1421000000 usd
CY2023Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
1307000000 usd
CY2024Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
480433000 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
819749000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
256527000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
320612000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6950928000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6825753000 usd
CY2024Q1 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
4862621000 usd
CY2023Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
4596156000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
473250000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
470232000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
261062000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
301752000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5596933000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5368140000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
475000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
475000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
129604492 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71463894 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128759639 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71715804 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
130000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
129000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3266185000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8422428000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8192659000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1289099000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
58140598 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
57043835 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3254421000 usd
CY2024Q1 us-gaap Selling Expense
SellingExpense
94188000 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
81592000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2534349000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2397279000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3382001000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1340847000 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
7209291000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
6887515000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3282359000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
27849000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
0 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3282270000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3282359000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15830131000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15476252000 usd
CY2024Q1 us-gaap Revenues
Revenues
935251000 usd
CY2023Q1 us-gaap Revenues
Revenues
901333000 usd
CY2024Q1 cpay Processing Expenses
ProcessingExpenses
207411000 usd
CY2023Q1 cpay Processing Expenses
ProcessingExpenses
204967000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
151262000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
154684000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
84760000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
84232000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-292000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-663000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
397338000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
375195000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
167000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
190000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3127000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-746000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-89088000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-79795000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-92048000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-80351000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
305290000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
294844000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75487000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80009000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
229803000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
214835000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
34000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
229769000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
214835000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.20
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.92
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.12
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.88
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71769000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73521000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73545000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74483000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
229803000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
214835000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-96112000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
81107000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
44122000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-5473000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-51990000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
75634000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
177813000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
290469000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-208000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
178021000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
290469000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3282359000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
229803000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-51990000 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
28057000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
321776000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24979000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
90838000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3282270000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2541493000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2541493000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
214835000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
214835000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
75634000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
75634000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9597000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9597000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26096000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26096000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33399000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33399000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2881860000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2881860000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
229803000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
214835000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
28931000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
25980000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
24979000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
26096000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25342000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
39270000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2029000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1787000 usd
CY2024Q1 cpay Amortization Of Intangible Assets And Investment Income Amortization Of Premium
AmortizationOfIntangibleAssetsAndInvestmentIncomeAmortizationOfPremium
55829000 usd
CY2023Q1 cpay Amortization Of Intangible Assets And Investment Income Amortization Of Premium
AmortizationOfIntangibleAssetsAndInvestmentIncomeAmortizationOfPremium
58252000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
647000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-499000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
167000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
190000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-292000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-663000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
382889000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-372342000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12587000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-40099000 usd
CY2024Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-1452000 usd
CY2023Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
28223000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
22021000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-25141000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
398544000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
102112000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
350184000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
877665000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
56325000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
126691000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41193000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36737000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4826000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4401000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102344000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-159027000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
90838000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
33399000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
288833000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9597000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
114000000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-3000000 usd
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3176000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2024Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
325000000 usd
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25531000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
23500000 usd
CY2024Q1 cpay Borrowings From Revolver
BorrowingsFromRevolver
1570000000 usd
CY2023Q1 cpay Borrowings From Revolver
BorrowingsFromRevolver
1964000000 usd
CY2024Q1 cpay Payments On Revolver
PaymentsOnRevolver
1866000000 usd
CY2023Q1 cpay Payments On Revolver
PaymentsOnRevolver
2490000000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-75429000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
310719000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
580000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
264000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-158551000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-217715000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-28148000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29298000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
61141000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
530221000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3141535000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2289180000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3202676000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2819401000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
115773000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
104650000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38925000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
35442000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. These financial statements were prepared using information reasonably available to us as of March 31, 2024 and through the date of this Quarterly Report. The accounting estimates used in the preparation of the Company’s interim consolidated financial statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment changes. Actual results may differ from these estimates.</span></div>
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3100000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-700000 usd
CY2024Q1 us-gaap Adjustment For Long Term Intercompany Transactions Net Of Tax
AdjustmentForLongTermIntercompanyTransactionsNetOfTax
-12400000 usd
CY2023Q1 us-gaap Adjustment For Long Term Intercompany Transactions Net Of Tax
AdjustmentForLongTermIntercompanyTransactionsNetOfTax
4900000 usd
CY2024Q1 us-gaap Revenues
Revenues
935300000 usd
CY2023Q1 us-gaap Revenues
Revenues
901300000 usd
CY2024Q1 us-gaap Revenues
Revenues
935300000 usd
CY2023Q1 us-gaap Revenues
Revenues
901300000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
42400000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
45700000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
29400000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
15700000 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment disclosures for the prior period have been reclassified to conform with current segment presentation.</span></div>
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3981890000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3648749000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
184887000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
180163000 usd
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
3797003000 usd
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
3468586000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
180163000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
149846000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25342000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
39270000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
19532000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
34128000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
3093000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
2444000 usd
CY2024Q1 cpay Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
-4179000 usd
CY2023Q1 cpay Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
3156000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
184887000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
160588000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1043710000 usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
205216000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1479453000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
315063000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
68300000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
69500000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
15000000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4400000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
129033000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4983000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
192.18
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3182000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
163.54
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
451039000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
138000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
251.10
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
95.87
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
539000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
167.72
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
64000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
14000 shares
CY2023Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
1307000000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6764054000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6722905000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1901433000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2126749000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
223.39
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4568000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
197.22
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2851000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
167.09
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
508550000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
866000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
234.40
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
468400000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y3M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
542000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
219.63
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
233000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
269.30
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
311000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
219.07
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
36000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
216.33
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
428000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
243.72
CY2023Q4 us-gaap Goodwill
Goodwill
5644958000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
77846000 usd
CY2024Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1058000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-50130000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
5673732000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3906846000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1873740000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2033106000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3921823000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1836160000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2085663000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
-15400000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55800000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
57700000 usd
CY2024Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
1339000 usd
CY2023Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
748000 usd
CY2024Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
5343054000 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
5415905000 usd
CY2024Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
1421000000 usd
CY2024Q1 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
4862621000 usd
CY2023Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
4596156000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6764054000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6722905000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-8500000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
229769000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
214835000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71769000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73521000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1776000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
962000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73545000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74483000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.20
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.92
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.12
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.88
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2024Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
63100000000 usd
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
56600000000 usd
CY2019Q1 cpay Derivative Number Of Cash Flow Hedges Entered Into
DerivativeNumberOfCashFlowHedgesEnteredInto
3 derivative_instrument
CY2023Q1 cpay Derivative Number Of Cash Flow Hedges Entered Into
DerivativeNumberOfCashFlowHedgesEnteredInto
5 derivative_instrument
CY2023Q3 cpay Derivative Number Of Cash Flow Hedges Entered Into
DerivativeNumberOfCashFlowHedgesEnteredInto
8 derivative_instrument
CY2023Q4 cpay Derivative Number Of Cash Flow Hedges Entered Into
DerivativeNumberOfCashFlowHedgesEnteredInto
5 derivative_instrument
CY2024Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
34300000 usd
CY2024Q1 cpay Payments For Derivative Termination
PaymentsForDerivativeTermination
3900000 usd
CY2024Q1 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
-22919000 usd
CY2024Q1 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
12688000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
16141000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-51748000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-200000 usd
CY2023Q1 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
77467000 usd
CY2023Q1 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
5089000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-3256000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
75634000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-021986-index-headers.html Edgar Link pending
0001628280-24-021986-index.html Edgar Link pending
0001628280-24-021986.txt Edgar Link pending
0001628280-24-021986-xbrl.zip Edgar Link pending
cpay-20240331.htm Edgar Link pending
cpay-20240331.xsd Edgar Link pending
ex311q12024.htm Edgar Link pending
ex312q12024.htm Edgar Link pending
ex321q12024.htm Edgar Link pending
ex322q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
cpay-20240331_def.xml Edgar Link unprocessable
cpay-20240331_lab.xml Edgar Link unprocessable
cpay-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cpay-20240331_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cpay-20240331_cal.xml Edgar Link unprocessable